ConvaTec Group PLC Director/PDMR Shareholding (4803Z)
10 Gennaio 2020 - 1:45PM
UK Regulatory
TIDMCTEC
RNS Number : 4803Z
ConvaTec Group PLC
10 January 2020
10 January 2020
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 8 January 2020, Dr Regina Benjamin, Non-Executive Director
and PDMR, purchased 10,000 Shares at GBP2.093361 per share. Dr
Benjamin's resulting shareholding is 10,000 Shares.
The attached notification, made in accordance with the
requirements of the EU Market Abuse Regulation, gives further
detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Dr Regina Benjamin
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")
instrument, type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction Purchase of Shares on 8 January 2020
c) Price(s) and volume(s) Price(s) Volume(s)
GBP2.093361 10,000
d) Aggregated information
- Aggregated volume 10,000
- Price GBP20,933.61
e) Date of the transaction 8 January 2020
f) Place of the transaction London Stock Exchange, Main Market (XLON)
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations +44 (0)7551 036
625
investorrelations@convatec.com
Media
Buchanan +44 (0)207 466 5000
Charles Ryland/Chris Lane/Vicky Hayns
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion devices. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFLFLFLDIILII
(END) Dow Jones Newswires
January 10, 2020 07:45 ET (12:45 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Apr 2023 a Apr 2024